| |
Test cases(n=62) |
Control(n=20) |
| Gender Male / Female |
46 / 16 |
16 / 4 |
| Age; yeas (median) |
39~82 (65) |
55~85 (71.5) |
| Tumor |
|
|
| Hepatocellular carcinoma |
23 (35.3%) |
9 (45.0%) |
| Peripheral Cholangiocarcinoma |
4 (6.4%) |
1 (5.0%) |
| Metastatic liver tumor*‡ |
35 (56.4%) |
10 (50.0%) |
| Background liver disease |
|
|
| Normal liver |
47 (75.8%) |
16 (80.0%) |
| Chronic hepatitis / advanced liver fibrosis / cirrhosis |
15 (24.1%) |
4 (20.0%) |
| HBV related |
6 (9.6%) |
2 (10.0%) |
| HCV related |
7 (11.2%) |
0 (0.0%) |
| Alcoholic |
2 (3.2%) |
0 (0.0%) |
| Non-alcoholic steatohepatitis |
0 (0.0%) |
2 (10.0%) |
| Type of Hepatectomy |
|
|
| Right hepatectomy |
49 (79.0%) |
1 (5.0%) |
| Left hepatectomy |
2 (3.2%) |
4 (20.0%) |
| Right trisegmentectomy |
3 (4.8%) |
0 (0.0%) |
| Left trisegmentectomy |
5 (8.0%) |
0 (0.0%) |
| Partial hepatectomy |
0 (0.0%) |
10 (50.0%) |
| Other procedures** |
3 (4.8%) |
5 (25.0%) |
| *Metastastic liver tumors of test cases; from 34 colorectal cancer, 1 gastrointestinal stromal tumor and 1 carcinoid tumor, and those of control cases; from 8 colorectal carcinoma, 1 gastric cancer, and 1 gastrointestinal stromal tumor.
**Other procedures containing bellow: Test cases; posterior segmentectomy, S1S2S3 segmentectomy, and S5S6S7 segmentectomy. Control; Anteriorsegmentectomy, central bisegmentectomy, lateral segmentectomy. |
|
